MCHR1 and anemia (phenotype): Incorporating MCHr into anemia management protocols across CKD stages may enhance diagnostic precision, reduce dependence on inflammation-sensitive markers like ferritin, and facilitate more cost-effective, individualized use of intravenous iron and ESAs.